Bioethics, Ltd.
BOTH
$1.25
$0.70127.27%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 39.30K | 23.00K | 27.20K | 13.60K | 10.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 39.30K | 23.00K | 27.20K | 13.60K | 10.00K |
| Operating Income | -39.30K | -23.00K | -27.20K | -13.60K | -10.00K |
| Income Before Tax | -53.10K | -35.90K | -39.70K | -24.40K | -22.30K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -53.10K | -35.90K | -39.70K | -24.40K | -22.30K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -53.10K | -35.90K | -39.70K | -24.40K | -22.30K |
| EBIT | -39.30K | -23.00K | -27.20K | -13.60K | -10.00K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.05 | -0.03 | -0.03 | -0.02 | -0.02 |
| Normalized Basic EPS | -0.03 | -0.02 | -0.02 | -0.01 | -0.01 |
| EPS Diluted | -0.05 | -0.03 | -0.03 | -0.02 | -0.02 |
| Normalized Diluted EPS | -0.03 | -0.02 | -0.02 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 1.14M | 1.14M | 1.14M | 1.14M | 1.14M |
| Average Diluted Shares Outstanding | 1.14M | 1.14M | 1.14M | 1.14M | 1.14M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |